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ABSTRACT 26 
 27 
Background: 28 
Chemsex (the combined use of drugs and sexual experiences) by MSM is associated with the 29 
transmission of STIs and BBVs, but psychosocial factors associated with chemsex 30 
engagement and remission remain unidentified. We considered: how do gay men self-identify 31 
a chemsex problem and remain chemsex free? 32 
 33 
Methods: 34 
Using a life course perspective this qualitative interview study examined participants’ 35 
reflections to discern pathways in and out of chemsex engagement. Six participants (aged 18 36 
years and over) were drawn from a cohort of men who had completed the tailored therapeutic 37 
Structured Weekend Antidote Programme (SWAP), run by London based LGBT non-38 
governmental organization London Friend. Transcripts were analysed using a Labovian 39 
narrative analysis framework. 40 
 41 
Results: 42 
Each man identified a multiplicity of incidents and feelings that contributed to their 43 
engagement in chemsex, and engagement in chemsex was connected to participants’ identity 44 
development and desire to belong to a gay community. Underlying individual accounts a 45 
common narrative suggested a process through which chemsex journeys were perceived as 46 
spiralling from exciting and self-exploratory incidents into an out of control high-risk activity 47 
that was isolating and prompted engagement with therapy. Despite seeking therapeutic 48 
engagement, participants’ expressed uncertainty about maintaining a gay future without 49 
chemsex. 50 
 51 
Conclusions: 52 
Findings indicated that chemsex was associated with a positive gay identity gain, which 53 
explained the ambivalence participants’ expressed in maintaining a gay future without 54 
chemsex despite their awareness of negative consequences. This is significant both for 55 
understanding why chemsex pathways may prove attractive, but also why they may be so 56 
difficult to leave. 57 
 58 
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KEY MESSAGES: 62 
 63 
 Participants’ identified multiple incidents and feelings as contributing to chemsex 64 
engagement 65 
 Chemsex engagement was connected to participants’ gay identity development  66 
 Chemsex journeys were perceived to spiral from exciting and exploratory into high-67 
risk activity  68 
 Association of chemsex with a gay identity gain explained ambivalence to remaining 69 
chemsex free   70 
INTRODUCTION 71 
Illicit drug use amongst men who have sex with men (MSM) in the UK is more prevalent 72 
than in the general population, with significant health implications.
1–3
 Research suggests that 73 
drug-use trends amongst some MSM are changing. Whereas ecstasy, amphetamine, cocaine 74 
and cannabis predominated pre-2007, more recently a new cohort of drugs has emerged, 75 
namely mephedrone, methamphetamine and gamma-hydroxybutyrate and its agonist gamma-76 
butyrolactone (GHB/GBL).
4–5
 Changing use patterns are also evidenced including increased 77 
intravenous use (referred to as “slamming”), polydrug use and the intentional combining of 78 
drugs and sex to enhance sexual experiences (“chemsex”). In chemsex, methamphetamine, 79 
mephedrone and GHB/GBL are used predominantly, henceforth referred to as chemsex 80 
drugs.
6–7
  81 
 82 
Existing studies have focused almost exclusively on the association between chemsex and 83 
sexual risk taking behaviour, specifically unprotected anal intercourse (UAI) and an increase 84 
in the spread of blood borne viruses (BBVs), particularly HIV which is high amongst UK 85 
MSM.
8–12
 Findings indicate that HIV-diagnosed MSM are more likely to engage in polydrug 86 
use compared to HIV-negative/undiagnosed MSM, and that this is associated with UAI and 87 
multiple new sexual partners.
13–14
 Associations between methamphetamine and erectile 88 
dysfunction drugs and condomless sex, including with HIV-serodiscordant status partners, 89 
are also evidenced.
15–17
 However, the percentage of UK MSM using chemsex drugs as a 90 
proportion of the gay and bisexual male population remains low, and the British Crime 91 
Survey 2013/14 reported that only 1% of gay and bisexual men had used methamphetamine 92 
in the last 12 months (although ten times higher than rates for other men).
18
 Additionally, 93 
MSM drug use has been found to be geographically varied, with gay community surveying in 94 
London indicating that 2.9% of gay and bisexual men had used methamphetamine within the 95 
previous four weeks compared to 0.7% elsewhere in England, with use generally episodic not 96 
daily.
19–20
 97 
 98 
Recent studies indicate that a complex array of factors shape lesbian, gay and bisexual (LGB) 99 
substance use pathways including the influence of social networks, living with HIV, the 100 
extent to which individuals live openly as LGB and the impact of MSM social spaces.
21, 4
 101 
There is however significantly less evidence on factors shaping chemsex pathways. The use 102 
of social media and online dating applications are thought to play a role in facilitating 103 
chemsex hook-ups.
19, 22
 Evidence suggests that methamphetamine is preferred because it 104 
enhances sexual experiences, lowers inhibitions and extends the length of sexual 105 
encounters.
16, 23
 Intravenous chemsex drug use is thought to be favoured due to the 106 
immediacy and intensity of the high produced.
13, 24
 Whatever the setting, men report that 107 
drugs and alcohol facilitate relaxation, raise self-confidence, alleviate social unease and fears 108 
about body image, age and HIV status.
25
 However, these studies have a fragmentary rather 109 
than pathway approach to understanding chemsex engagement, maintenance and 110 
disengagement. 111 
 112 
Research Aim 113 
Research exploring chemsex has predominantly focused on detailing prevalence and risk 114 
rather than understanding the dynamic, multiple factors across an individual’s life course 115 
shaping the development of chemsex pathways. These approaches miss the possibility that 116 
drug use amongst some MSM may form what Dingle, Cruwys and Frings refer to as an 117 
“identity gain pathway” through addiction – enabling the development of new, highly valued 118 
social identities, particularly by socially isolated individuals.
26
 A more detailed analysis of 119 
chemsex pathways could therefore provide insight for the development of tailored treatment 120 
for MSM engaging in chemsex.  121 
 122 
The aim of this explorative qualitative study was to ask gay men who had attended a chemsex 123 
recovery programme to tell their chemsex stories within the context of their life story as a gay 124 
man. Thus enabling a consideration of how these narrative stories were constructed within 125 
changing social and cultural contexts to examine how gay men themselves viewed their 126 
journey into and out of chemsex. 127 
 128 
METHOD 129 
Participants 130 
As this was an exploratory study, recruitment criteria were kept to a minimum: participants 131 
had to be over 18, self-define as a gay man and be living in London. Six participants were 132 
drawn from a cohort who had completed the tailored therapeutic Structured Weekend 133 
Antidote Programme (SWAP) run by London based LGBT non-governmental organization 134 
London Friend. A pool of 33 men had graduated from the programme and consented to 135 
further contact. The study was given ethical clearance by the review board of the Department 136 
of Psychological Sciences, Birkbeck University of London. Participants’ ages ranged from 30 137 
to 60 years. Four participants identified as white British, and two as white European. Four 138 
identified their social class as middle class, and two as working class. Table 1 details 139 
participants’ substance use based on their last use episode. Three substances predominated: 140 
methamphetamine, GHB/GBL and mephedrone. Four participants reported injecting drugs 141 
(67%), and all reported polydrug use and use in a sexual context, five with multiple partners 142 
(83%).   143 
Procedure and Interviews 144 
Semi-structured interviews lasting approximately 2 hours each were conducted at London 145 
Friend in 2015. The interviewer had relevant prior work experience at London Friend and in 146 
an NHS substance use setting. Interviews began with an invitation to the participant to tell 147 
their story of how they came to develop a problem with chemsex, and what factors across 148 
their life they thought may have contributed to this. The interviewer’s approach was to 149 
sympathetically receive participants’ narratives and keep the research focus in mind with 150 
prompts to encourage expansion upon the episodes they narrated (for example, ‘Can you tell 151 
me a little more about that?’).  152 
 153 
Participants were fully debriefed following the interview and able to reflect on any issues 154 
discussed before self-completing a brief demographic and substance use information 155 
questionnaire. Interviews were audio recorded with participants’ consent and transcribed 156 
verbatim. Any identifying details, including names, locations and occupations were changed 157 
to ensure anonymity. Participant names as cited in the text here are pseudonyms chosen by 158 
the interviewee to avoid revealing identifying information  159 
 160 
The verbatim interview transcript extracts presented in this paper use the following notation: 161 
a short pause in narration…, text removed (…), and text added for clarity or changed for 162 
confidentiality [clarification]. 163 
 164 
Narrative Analysis 165 
A lifecourse perspective was adopted to enable to consideration of participants’ chemsex 166 
stories within the context of their life to date. The life course perspective emphasises the 167 
multiple temporal contexts of individual development, acknowledging how timing, culture, 168 
historical and local context, and relationship networks influence individual development 169 
across the lifespan.
 27-29
 Understanding how individuals process transitions and critical life 170 
events within these multiple contexts, is vital to comprehending the multiplicity of pathways 171 
developed across their lifespan, and can equip treatment providers with the necessary 172 
information to support individuals in developing less harmful pathways across their life 173 
course.
 36
 Narrative analysis enables the structuring the lived experiences a participant states 174 
into as a series of events or episodes (micro-narratives) within an overarching life story 175 
(macro-narrative). Thus, the resultant framework of findings is particularly useful for 176 
understanding how individuals make sense of and attempt to integrate traumatic life events 177 
within the context of their life story.
 30
  178 
 179 
The narrative analysis of interview transcripts proceeded as follows. Initially a summary was 180 
written detailing the macro-narrative (the overarching life story) apparent in each 181 
participant’s account, as suggested by Murray.30 Subsequently, each stated event or episode 182 
was re-structured as a micro-narrative and then situated chronologically within each 183 
participant’s account of their life. Macro and micro-narratives were analysed using a 184 
Labovian analysis framework focusing on analysing the sequence and structural parts of each 185 
narrative within and across stories. A Labovian analysis (depicted in Table 2) breaks down 186 
each micro or macro narrative identified into different segments: abstract (what the narrative 187 
is about); orientation (context detail provided); complicating action (what happened); 188 
evaluation (what was thought about what happened); resolution (how this was resolved); coda 189 
(the point of the story for current identity).Labovian analysis therefore allows for an 190 
exploration of  how participants storied their lives to account for their chemsex story.
31-33
 191 
Combining a life course perspective and Labovian narrative analysis (termed “narrative 192 
engagement”) is useful for understanding the development of lived sexual identity through 193 
the analysis of key incidents (i.e. complicating actions) within historical and social contexts, 194 
family and the intimate relationships in which they occur.
 34
  195 
 196 
The first author, who was also the interviewer, conducted the initial analysis, which was then 197 
elaborated and agreed upon with the second author. A draft of the findings and interpretations 198 
were then discussed separately with staff at London Friend. 199 
 200 
RESULTS 201 
From the macro-narrative accounts of the six men a commonly told chemsex story emerged, 202 
highlighting a previously unexplored aspect of chemsex – “spiralling” – the process by which 203 
chemsex journeys evolved. Spiralling was seen in various micro-episodes that men told about 204 
specific chemsex incidents. Figure 1 illustrates one participant’s spiral and Table 3 205 
summarises the key episodes represented across the spiral with excerpts from different men’s 206 
transcripts. The shared chemsex journey became discernible when comparing different 207 
participants’ spirals: Participants’ were offered and tried chemsex drugs in what they denoted 208 
to be a setting for gay men; chemsex engagement was evaluated as positive and increased; 209 
participants’ began to re-evaluate their chemsex experiences in light of increasingly negative 210 
episodes; participants’ sought support for addressing their chemsex behaviour. Participants’ 211 
spirals all indicated three central themes: acceptance and belonging, life on the verge of 212 
collapse, and the uncertainty of a future without chemsex. These three themes are detailed 213 
below with evidence from the interview transcripts.214 
 215 
Acceptance and belonging 216 
Finding a space for their sexuality to be accepted and endorsed as a gay man was emphasised 217 
by each participants as a positive and enduring aspect of their chemsex journey. Thus, all 218 
participants described physical relocation as a significant life-event in this process, 219 
facilitating identity exploration, the establishment of new social networks and sexual 220 
exploration (aided by chemsex drugs). John for example described moving to a larger city: 221 
“It was… like my birth because it was the first time in my life I’d been popular, it was the 222 
first time in my life I wasn’t bullied, wasn’t picked on… I realised I was funny, I was 223 
attractive”.   224 
 225 
All participants’ described chemsex drugs as enabling sexual exploration which in turn 226 
deepened their sense of belonging as a gay man and prompted further exploration. These 227 
micro-episodes were often framed in terms of rebellion and pushing back boundaries, as Paul 228 
described when reflecting on attempting fisting: “There’s a reality of your body’s limit. It 229 
[crystal methamphetamine] does relax you sufficiently and give you the desire to want to do 230 
that”. Five participants also noted how chemsex drugs had helped them overcome a lack of 231 
confidence, particularly in relation to sex and socialising, as Iggy commented: “I felt so 232 
sexually confident (…) and I sort of felt like I had gone through my second burst (…) So 233 
basically mephedrone made me into a sexual animal and it was great”.  234 
 235 
Life on the verge of collapse 236 
Despite the positive aspects of chemsex articulated in their initial experiences, towards the 237 
middle of each spiral participants described numerous micro-episodes which they evaluated 238 
negatively. These were compiled and indicated a growing sense of crisis, as Peter 239 
summarised:  “I didn’t seem to be able to have a stop button (…) multiple tracks of my life 240 
were on the verge of collapse (…) I was going to work not able to concentrate (…) my 241 
finances were suffering (…) I wasn’t seeing my friends (…) I was concerned that I would get 242 
evicted”.  243 
 244 
Chemsex was increasingly evaluated as negative as participants became concerned that they 245 
may not be able to return to enjoying sober sex. As Robert articulated: “It [chemsex] has 246 
totally destroyed my sexual life… I don’t have sober sex (…) I can’t have normal sex 247 
anymore”. Three men additionally found themselves taking sexual risks as a consequence of 248 
intoxication, as Frederick described: “Crystal meth [methamphetamine] makes me not care 249 
about anything in a much more intense way than the other drugs (…) it makes anything 250 
dangerous or risky, more sexy”. Three participants attributed their HIV diagnosis to lowered 251 
inhibitions following drug use, and described an escalation in chemsex following diagnoses 252 
which they attributed to associated feelings of guilt and shame, as John stated: “Things got 253 
darker for me when I was diagnosed HIV (…) I felt like a broken toilet and I had put myself 254 
in the BB [UAI] chemsex role (…) the guilt defined me and led me into a black hole”. 255 
 256 
Three participants touched on the sexualisation of addiction within their chemsex circles, 257 
which prompted a shift to intravenous drug-use. Paul believed that he was deliberately 258 
infected with hepatitis C by a sexual partner who seemed to experience sexual excitement 259 
when sharing blood through injecting. Yet, despite this, Paul continued to attend chemsex 260 
parties and allow other men to inject him: “Several times I would say ‘Right this is stupid I 261 
have to stop’ (…) there were really bad experiences (…) So you have a period of abstinence, 262 
and then you think you can handle it, and anyway the urge to have sex doesn’t go away”.  263 
 264 
Uncertainty of a future without chemsex 265 
Deciding to address their chemsex behaviour signalled a shift towards the ending of each 266 
man’s chemsex story. This turning point was followed in each narrative by participants’ 267 
evaluating their entire chemsex journey within the context of their life course, reflecting on 268 
the difficulty they had stopping chemsex and how this was an ongoing process wrought with 269 
uncertainty about the future. Four participants’ reflected on feelings of emptiness and loss 270 
when having sober sex, commenting on the difficulty in creating intimacy without drugs. As 271 
Iggy said: Sober sex makes me sad that I don’t have a boyfriend and I’m not making love and 272 
I think with mephedrone it fills that void, it fills that emptiness”. Three participants said that 273 
they welcomed the sexual exploration chemsex enabled, despite their concerns about their 274 
chemsex behaviour. As Frederik summarised: “If it wasn’t for my early drug use I would be a 275 
completely different person. It is quite important to admit that I think that it has had positive 276 
effects (…) I am a much more confident person”. Finally, three participants described a fear 277 
of losing the self-confidence they felt they had gained from chemsex. Peter for example noted 278 
how tenuous his sobriety was in the face of potential future life challenges stating: “I’m very 279 
aware if something breaks down I have to be very careful (…) I’m a bit apprehensive about 280 
it”. Only one man described engaging in a satisfying sober sex experience since deciding to 281 
stop chemsex. Consequently, five participants reflected that they might choose to have 282 
chemsex experiences in the future, although stating that this would be under more controlled 283 
circumstances. 284 
 285 
DISCUSSION 286 
The current study explored the factors that gay men who sought therapy believed to have 287 
contributed to their developing a problem with chemsex and their decision to seek help. 288 
Participants’ narratives revealed how chemsex engagement marked turning points within 289 
their life trajectories by initially positively challenging and expanding their existing 290 
biographies, but then having a far reaching, painful impact across their lives. A hitherto 291 
unidentified aspect of chemsex experiences was the process by which chemsex journeys 292 
spiralled from exciting and self-exploratory into feeling out of control, isolating and high-293 
risk. This emerged from the Labovian structural narrative analysis of men’s macro and micro-294 
narratives, and illuminated how each participant, following their decision to engage in 295 
chemsex, recounted a series of episodes in which they faced complicating actions related to 296 
their chemsex experiences that they began to evaluate as negative. This sequence of episodes 297 
contributed towards each man resolving to address their chemsex behaviour, leading to 298 
engagement with London Friend and participation in SWAP. 299 
 300 
Previous studies have indicated different motivational factors associated with chemsex use. 301 
Reflecting existing findings, all participants described their initial chemsex experience as 302 
pleasurable, enabling sexual exploration, deepening their intensity and intimacy.
17, 24
 For 303 
three men the element of rebellion and risk taking, including injecting drugs, heightened the 304 
pleasure of the experience, although also creating feelings of guilt and shame. All participants 305 
identified drug use as fulfilling a range of complex functions beyond improving their sex 306 
lives, including overcoming low self-confidence and social and sexual anxiety, as indicated in 307 
previous studies.
3, 25, 26
 Previous research has suggested that some HIV diagnosed men use 308 
drugs to escape negative feelings associated with their diagnosis. Similarly three participants’ 309 
in this study reported use escalation following BBV diagnosis in response to such feelings.
 18, 310 
24
   311 
 312 
As suggested by previous studies exploring the sex lives MSM want,
 
the fear of not being 313 
able to have the type and variety of sex desired or the depth of intimacy of sexual experience, 314 
coupled with sexual performance and body anxiety and low self-confidence, continued to 315 
exert a powerful influence on decisions about a future without chemsex.
 20, 25
 The current 316 
study captured the contradictory nature of participants’ chemsex experience: participants 317 
enjoyed the intensity and intimacy chemsex enabled and feared being unable to replicate this 318 
when having sober sex, yet they battled with what they saw as the increasingly negative 319 
consequences of chemsex.  320 
 321 
A life course perspective proved vital in illuminating how chemsex experiences were nested 322 
within the context of personal biography (including “coming-out” experiences), social and 323 
historical contexts, timing, and social networks. For all of the men, chemsex was intimately 324 
connected to their identity development and their experiences of living as a gay man, finding 325 
spaces to belong in within gay communities and relationships. Our results uniquely indicate 326 
that rather than chemsex simply being associated with the loss of an established identity, 327 
chemsex was associated with a positive gay identity gain. Thus, the process of gay identity 328 
gain experienced through chemsex use, which has been more generally suggested by Dingle 329 
et al. in relation to addition
26
, could explain the ambivalence and uncertainty expressed by all 330 
the men in maintaining a gay future without chemsex, despite the realization of negative 331 
consequences.
 
 332 
 333 
Limitations  334 
The current exploratory study provided a qualitative insight into the experiences of only six 335 
gay men living in London who had completed a therapeutic programme aimed at chemsex 336 
recovery. Engagement in a service to address their chemsex behaviour meant that the men 337 
had already been considering the factors in their lives shaping their chemsex patterns, and this 338 
alone could have enabled a common story to emerge. In addition, fully briefing participants 339 
by sharing the interview schedule in advance may have actively encouraged prior framing of 340 
personal stories. Future studies should therefore access a more representative sample of 341 
MSM, including men who have not yet begun to address their chemsex behaviour. 342 
 343 
CONCLUSIONS 344 
The current study adopted a holistic approach to explore factors gay men believe contributed 345 
to their chemsex journey, beyond simply considering contributory factors and consequences 346 
in isolation. The process of narrative engagement as outlined by Hammack and Cohler
34
 347 
illuminated the intersection of historical factors, sociocultural contexts, social networks and 348 
relationships and timing in shaping gay men’s chemsex pathways. Our findings support 349 
previous evidence indicating that a life course approach to gay men’s health is vital to 350 
understanding and supporting gay men both in preventative programs prior to engagement in 351 
potentially harmful practices and in intervention programs. 
35–36
 In locating their chemsex 352 
stories within their existing biographical narrative, participants were able to identify the 353 
multiplicity of factors across their lifespan which contributed to their chemsex engagement. 354 
As such, for these men, chemsex was not just about sex, but emerged as part of their ongoing 355 
journey to define themselves as gay men. This is significant both for understanding why 356 
chemsex pathways may prove attractive, but also why they may be so difficult to leave 357 
despite therapeutic intervention and continued negative consequences. A more detailed 358 
analysis of chemsex pathways could provide useful insight for the development of tailored 359 
treatment for MSM engaging in chemsex. 360 
  361 
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Table 1  
Participant Substance Use Information at Last Use Episode  
 
Participant 
Pseudonym 
Substance Method Frequency Concurrent 
Use 
Amount Context 
Robert GBL 
Crystal 
methamphetamine 
Mephedrone 
Oral 
Smoke 
Snort 
Monthly 
Monthly 
Monthly 
Yes 10ml 
¼ g 
10g 
Chemsex (one-to-
one) 
Iggy Mephedrone 
 
Cannabis 
Snort 
 
Smoke 
Monthly 
 
Daily 
Yes 
 
 
3g 
 
-  
Chemsex (one-to-
one, sex parties*) 
On own 
Paul Crystal 
methamphetamine 
GBL 
IV, smoke, booty bump, piss-
fuck 
Oral 
Monthly 
Monthly 
Yes 2g 
3ml 
Chemsex (one-to-
one and sex parties*) 
Peter Mephedrone 
GBL 
Snort 
Oral 
Every 3 weeks 
Every 2 
months 
Yes 3g 
3ml 
Chemsex (one-to-
one and sex parties) 
John Crystal 
methamphetamine  
GBL 
Mephedrone 
MDMA 
IV, smoke, piss-fuck 
Oral 
IV, booty bump 
Bomb, booty bump 
Every 6-8 
weeks 
Every 6-8 
weeks 
Every 6-8 
weeks 
Every 6-8 
weeks 
Yes 3g 
120ml 
6g 
1g 
Chemsex (one-to-
one and sex parties) 
 
Frederik 
Crystal 
methamphetamine  
GBL 
IV 
Oral 
Monthly 
Monthly 
Yes 1g 
7ml 
Chemsex (one-to-
one and sex parties) 
 
Note: - Indicates where participant was unable to specify the amount used. * Sex with multiple partners.
Table 2  
The Main Stages of the Macro-Narratives of Participant’s Chemsex Stories in Labovian Narrative Form 
 
Abstract Participants' reflect on their chemsex journey as part of seeking a way out of their problems with chemsex. 
Orientation The men are introduced to chemsex drugs in a sexual context, having previously observed the use of these 
drugs amongst their social circle, but without trying them. 
 
Complicating Action Disruptions to participant’s life due to chemsex engagement. 
 
Evaluation Participant evaluates their chemsex experience as increasingly negative. 
 
Resolution Each man reaches the conclusion that the costs of chemsex have become too high and needed to be addressed, 
leading them to seek support from a drug and alcohol service. 
 
Coda The process of addressing chemsex behaviour leads to a re-evaluation of their chemsex experiences with each 
man weighing up both the negative and positive outcomes of chemsex episodes. Participants’ reflect on the loss 
they felt at giving up chemsex and removing themselves from chemsex circles – leaving a dilemma of how to 
reconstruct their gay identity without chemsex. 
 
  
Table 3 
The Episodes (Micro-Narratives) of Fredrick’s Chemsex Story with Brief Transcript Excerpts 
 
Episode Brief Transcript Excerpt Transcript 
Reference 
Moved to London “To be thrown into a foreign city, it was quite traumatic” P.8, L.399 
Acceptance onto gay clubbing scene “It was the first time that I felt like I really belonged somewhere in the gay 
community” 
 
Feelings of shame and unworthiness 
following HIV and Hepatitis C diagnosis 
“I think my drug problem came out of a subconscious desire to kill that part of 
me that I perceived as having become undesirable” 
P.6, L.258 
Long term relationship ends “Several events happened HIV, Hepatitis, break up of my relationship that 
meant I was in a place where it’s ‘well the worst things have happened now so 
what, what does anything matter now’” 
P.5, L234 
Introduced to chemsex drugs at a sex 
party 
“It [methamphetamine] was introduced to me in an environment where I was 
already high and with people I trusted…it was a progress thing” 
P.14, L.679 
Starts intravenous methamphetamine use “I smoked for quite a few years before injecting because I thought it was sick… 
and the thing is that I was exposed to it often enough… after I while I could see 
what it was doing to them [sexually] and I wanted that” 
P.18, L.857 
Increasingly isolated from non-chemsex 
friends 
“I supposed I gravitated to people who fetishized injecting… I only have one 
friend who knows that I’ve injected… I rarely have friends that I talked about 
my sex life with” 
P17., L.807 
Increased sexual-risk taking “Crystal meth… makes me not care about anything… it makes anything that is 
dangerous or risky more sexy… having sex where I don’t care, I don’t care 
what I catch and I’m not proud to say I don’t care what anyone else catches” 
P.5, L.207 
Financial difficulties “I’m spending money I don’t have, and I’m missing work” P.19, L.913 
Seeks help for drug use “What first brought me to Antidote [drug service] was when I first started 
taking those club drugs in connection with sex because I felt such shame and 
guilt” 
P.10, L.480 
Uncertain about future without chemsex “The thought of leaving it behind brings up a primal subconscious fear…a lot of 
my sexual confidence is entirely wrapped up in that [chemsex]” 
P.9, L417 
 
Figure 1 
Fredrick’s Chemsex Spiral 
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